Results 91 to 100 of about 9,259 (230)
Ageing patients with severe haemophilia: complications and comorbidities
Background: Advances in the treatment of haemophilia patients have led to a significant increase in life expectancy. Diseases and conditions developing now were not previously encountered in this population group as patients were dying younger ...
Saša Anžej Doma+3 more
doaj
Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994 [PDF]
F. Giannelli+9 more
openalex +1 more source
European Principles of Nursing Care for Persons With Inherited Bleeding Disorders
ABSTRACT Introduction A nurse is one of the core members of the multidisciplinary haemophilia team. However, what people with inherited bleeding disorders (PwBD) can expect from them has not yet been formally defined. Aim This project, initiated by the EAHAD Nurses Committee, aimed to establish Principles of Nursing Care (PoNC) for PwBD to promote high‐
Nanda Uitslager+4 more
wiley +1 more source
Consequences of factor IX mutations in 26 families with haemophilia B [PDF]
Ann F. Weinmann+2 more
openalex +1 more source
ABSTRACT Introduction Treatment decision making can be complex and challenging for people with haemophilia (PwH) and their caregivers. A shared decision‐making (SDM) approach can ensure that decisions about treatment and care incorporate patients’ beliefs, values, and preferences.
Laura Meade+6 more
wiley +1 more source
Introduction: Concizumab is a once-daily prophylactic treatment in development for haemophilia A or B with or without inhibitors, and it is potentially the first treatment for haemophilia patients to be delivered subcutaneously using a prefilled, multi ...
NK Rasmussen+6 more
doaj
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries. [PDF]
Funding E+7 more
europepmc +1 more source
Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir [PDF]
Juzo Matsuda+2 more
openalex +1 more source
Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors
Rheumatology &Autoimmunity, EarlyView.
Lifang Wang+3 more
wiley +1 more source
ABSTRACT Introduction Decision‐making in haemophilia is challenging due to the small evidence base, disease heterogeneity, and inter‐patient variability. Shared decision‐making (SDM) supports patient‐clinician decisions. Aim Creation of a two‐sided decision box facilitating SDM for haemophilia patients switching from conventional (weight‐based) to ...
Arun Keepanasseril+4 more
wiley +1 more source